04/16/2024
6:01 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:41 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
3:19 PM | Cavalie Fanny (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:09 AM | Foghorn Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
6:11 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/02/2023
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:08 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/08/2023
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:33 PM | Agresta Samuel (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
6:08 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/28/2023
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
7:10 PM | Foghorn Therapeutics (Issuer)
Mendelsohn Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:11 PM | Foghorn Therapeutics (Issuer)
GILL SIMBA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:12 PM | Foghorn Therapeutics (Issuer)
Koppel Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:13 PM | Biller Scott (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:13 PM | Foghorn Therapeutics (Issuer)
SMITH IAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:14 PM | Cole Douglas G. (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:14 PM | Foghorn Therapeutics (Issuer)
Lynch Thomas J. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:15 PM | Foghorn Therapeutics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:13 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
6:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
8:22 PM | Foghorn Therapeutics (Issuer)
GOTTSCHALK ADRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
6:05 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023
6:07 AM | Foghorn Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
